CIENCIASMEDICASNEWS: What is Recombumin? | Medical News

miércoles, 27 de febrero de 2019

What is Recombumin? | Medical News | Medical Articles

	February 27, 2019
	Genetics
	The latest Genetics news from News Medical

What is Recombumin?

A well-described carrier protein which is present in high concentrations (40-50 g/L) in plasma, Albumin has a circulatory half-life of roughly 19 days. It has a number of functions, including protein stabilization, the ability to bind both metal ions and to surfaces, fatty acid transportation to tissues, and an anti-oxidative effect in plasma.

Read Full Article Here

Researchers reveal novel computational tool used to analyze genetic variation

The field of genetic sequencing has undergone a dramatic revolution over the past 20 years. In 2001 the first copy of the three billion base pairs that assemble the human genome was published.

Sample Preparation of Biological Materials — From Cell Disruption to Homogenization and Pulverization

From Bead Beating for cell disruption over homogenization and pulverization to cryogenic grinding: for these applications the use of a mixer mill yields optimum results - and often better than standard methods like vortexing.

Learn More

New DNA-based nanomachines can be used for gene therapy of cancer

Scientists from ITMO in collaboration with their international colleagues proposed new DNA-based nanomachines that can be used for gene therapy of cancer.

	Scientists develop novel way with genome sequences to study widespread form of malaria Scientists at the Institute of Genome Sciences at the University of Maryland School of Medicine have developed a novel way with genome sequences to study and better understand transmission, treat and ultimately eradicate Plasmodium vivax, the most widespread form of malaria. P. vivax is a single-celled transmitted by mosquitoes.

	Research sheds light on how motor enzyme can promote genome integrity Approximately one per cent of each organism's genome encodes helicases. Helicases are mostly known as motor enzymes that can unwrap double-stranded DNA by use of energy.

	Newly discovered genetic disorder opens way for future diabetes drugs Knowledge of a newly discovered genetic disorder, which means that a person cannot produce the protein TXNIP (thioredoxin interacting protein) in their cells, can open for the development of new diabetes drugs.

	Whole-genome sequencing and sharing real-time data could limit spread of foodborne bacteria Employing advanced genetic-tracing techniques and sharing the data produced in real time could limit the spread of bacteria -- Bacillus cereus -- which cause foodborne illness, according to researchers who implemented whole-genome sequencing of a pathogen-outbreak investigation.